TG Therapeutics Inc’s recently made public that its Director Lonial Sagar unloaded Company’s shares for reported $0.15 million on Nov 11 ’24. In the deal valued at $30.44 per share,5,000 shares were sold. As a result of this transaction, Lonial Sagar now holds 100,195 shares worth roughly $3.43 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Charney Laurence N sold 25,000 shares, generating $754,875 in total proceeds. Upon selling the shares at $30.20, the Director now owns 212,479 shares.
Before that, Charney Laurence N bought 25,000 shares. TG Therapeutics Inc shares valued at $754,873 were divested by the Director at a price of $30.19 per share.
TD Cowen initiated its TG Therapeutics Inc [TGTX] rating to a Buy in a research note published on October 29, 2024; the price target was $50. A number of analysts have revised their coverage, including Goldman’s analysts, who increased its forecast for the stock in early August from “a Sell” to “a Neutral”. BofA Securities started covering the stock on May 20, 2022. It rated TGTX as “an Underperform”.
Price Performance Review of TGTX
On Tuesday, TG Therapeutics Inc [NASDAQ:TGTX] saw its stock fall -1.01% to $34.26. Over the last five days, the stock has gained 12.99%. TG Therapeutics Inc shares have risen nearly 100.59% since the year began. Nevertheless, the stocks have risen 170.19% over the past one year. While a 52-week high of $36.84 was reached on 11/25/24, a 52-week low of $12.30 was recorded on 02/21/24. SMA at 50 days reached $25.99, while 200 days put it at $19.91.
Levels Of Support And Resistance For TGTX Stock
The 24-hour chart illustrates a support level at 33.69, which if violated will result in even more drops to 33.13. On the upside, there is a resistance level at 34.77. A further resistance level may holdings at 35.29. The Relative Strength Index (RSI) on the 14-day chart is 66.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.99, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 26.35%. Stochastics %K at 80.57% indicates the stock is a selling.
How much short interest is there in TG Therapeutics Inc?
A steep rise in short interest was recorded in TG Therapeutics Inc stocks on 2024-11-15, dropping by -4.15 million shares to a total of 28.33 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 32.48 million shares. There was a decline of -14.67%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 23, 2022 when B. Riley Securities resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $35.
